Adi Mohanty
Amministratore Delegato presso BIORA THERAPEUTICS, INC.
Patrimonio netto: 97 752 $ in data 30/04/2024
Provenienza dei contatti di primo grado di Adi Mohanty
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
52
| Subsidiary | Pharmaceuticals: Major | 52 |
| Public Company | Biotechnology | 21 | |
| Public Company | Biotechnology | 16 | |
| Public Company | Medical/Nursing Services | 15 | |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA.
13
| Extinct | Miscellaneous Commercial Services | 13 |
| Subsidiary | Biotechnology | 11 | |
Cell Cure Neurosciences Ltd.
 Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel.
7
| Subsidiary | Biotechnology | 7 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.
5
| Subsidiary | Medical Specialties | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Adi Mohanty tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| MALLINCKRODT PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chairman General Counsel Chief Tech/Sci/R&D Officer General Counsel | |
| QUESTCOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Operating Officer Chief Executive Officer Director/Board Member Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Michigan | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Sales & Marketing | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| University of California, Davis | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Weizmann Institute of Science | College/University | Director of Finance/CFO Doctorate Degree Graduate Degree | |
ES Cell International Pte Ltd.
 ES Cell International Pte Ltd. BiotechnologyHealth Technology ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore. | Biotechnology | Chief Executive Officer Chief Operating Officer Founder | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Director/Board Member | |
| AFFYMETRIX, INC. | Medical Specialties | Chief Operating Officer Corporate Officer/Principal | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
| INTERMUNE INC | Biotechnology | Director/Board Member Director/Board Member | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Rensselaer Polytechnic Institute | College/University | Undergraduate Degree Undergraduate Degree | |
| University of East London | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
| INSMED INCORPORATED | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| Bucknell University | College/University | Undergraduate Degree Undergraduate Degree | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
| SEQUENOM, INC. | Medical Specialties | General Counsel Sales & Marketing | |
| Emory University | College/University | Doctorate Degree Undergraduate Degree | |
| SAVARA INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| ROCKWELL MEDICAL, INC. | Medical Specialties | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of San Francisco | College/University | Undergraduate Degree Graduate Degree | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Doctorate Degree | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| CENTOGENE N.V. | Miscellaneous Commercial Services | Chairman Director of Finance/CFO | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 40 |
| Regno Unito | 5 |
| Irlanda | 3 |
| Israele | 2 |
| Canada | 2 |
Settori
| Health Technology | 28 |
| Consumer Services | 19 |
| Commercial Services | 5 |
| Finance | 2 |
Posizioni
| Director/Board Member | 465 |
| Corporate Officer/Principal | 233 |
| Independent Dir/Board Member | 134 |
| Director of Finance/CFO | 120 |
| Chairman | 90 |
Contatti più connessi
| Insiders | |
|---|---|
| Steven Gillis | 58 |
| Daniel Geffken | 53 |
| Jonathan Leff | 45 |
| Simon Gibbins | 40 |
| Raf Hofstein | 36 |
| Flemming Ørnskov | 34 |
| David Schlachet | 28 |
| William Burns | 27 |
| Ronald Andrews | 27 |
| Andy Arno | 25 |
| Susan Kilsby | 24 |
| Michael West | 21 |
| Brian Kotzin | 20 |
| Tamara Joseph | 19 |
| David Stout | 19 |
- Borsa valori
- Insiders
- Adi Mohanty
- Connessioni Società
